Thanks kpax. I see what you've done and the time, and more time, it would have taken.Been pondering monepantel and it seems to me that with its attributes, monepantel is fairly described as an immuno-oncology drug or at minimum, as a complementary I-O drug.
I-O is the future of cancer treatment and to place it there, I think every announcement should be prefaced "Immuno-oncology drug, moneptantel ...What do you think?
Covi-Pantel . NZ Trader Release, page-1128
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.00M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.5¢ | $101.0K | 508.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 420397 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 8821 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |